Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores
Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and dat...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2023-11, Vol.12 (21), p.6813 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 21 |
container_start_page | 6813 |
container_title | Journal of clinical medicine |
container_volume | 12 |
creator | Herzum, Astrid Occella, Corrado Gariazzo, Lodovica Pastorino, Carlotta Viglizzo, Gianmaria |
description | Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence. |
doi_str_mv | 10.3390/jcm12216813 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2889995179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A772533471</galeid><sourcerecordid>A772533471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</originalsourceid><addsrcrecordid>eNptkU1rGzEQhpfSQkOSU_-AIJdAcaIPb0abm9k2TSDBJknPy6xWsuXsrlyNTMklv70yCeSDag6aGZ73ZZgpim-CnyhV8dO1GYSU4kwL9anYkxxgwpVWn9_kX4tDojXPT-upFLBXPNUhJm_CZhVajwyHMC7ZAqMdE7HgWL3yfZcr9tenFZulsPGG_bBxwOSTp3M2I7JEPqtucB0iw7FjN37M2a2nB3aBJoVIzOXGpV-u2P18cVXPF-zOhGjpoPjisCd7-PLvF78vft7Xl5Pr-a-renY9MarSaeIAnJCdECaPrUTrVGfOuK6qslQdyBYdVrI1ILBUTluBGqAE5BKgcy1KtV8cP_tuYviztZSawZOxfY-jDVtqpM5mVSmgyujRB3QdtnHM0-0oLYDrcvpKLbG3jR9dSBHNzrSZAchSqSmITJ38h8rR2SEvfbTO5_47wfdngYmBKFrXbKIfMD42gje7Kzdvrqz-AURMl9U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2888170854</pqid></control><display><type>article</type><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</creator><creatorcontrib>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</creatorcontrib><description><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm12216813</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Allergy in children ; Atopic dermatitis ; Atrophy ; Clinical medicine ; Corticosteroids ; Dermatitis ; Dermatology ; Drug therapy ; Eczema ; False information ; Fear & phobias ; Parents ; Parents & parenting ; Pediatrics ; Phobias ; Psychological aspects ; Questionnaires ; Risk factors ; Steroids ; Surveys ; Topical medication</subject><ispartof>Journal of clinical medicine, 2023-11, Vol.12 (21), p.6813</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</citedby><cites>FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</cites><orcidid>0000-0001-6373-8801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Herzum, Astrid</creatorcontrib><creatorcontrib>Occella, Corrado</creatorcontrib><creatorcontrib>Gariazzo, Lodovica</creatorcontrib><creatorcontrib>Pastorino, Carlotta</creatorcontrib><creatorcontrib>Viglizzo, Gianmaria</creatorcontrib><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><title>Journal of clinical medicine</title><description><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></description><subject>Allergy in children</subject><subject>Atopic dermatitis</subject><subject>Atrophy</subject><subject>Clinical medicine</subject><subject>Corticosteroids</subject><subject>Dermatitis</subject><subject>Dermatology</subject><subject>Drug therapy</subject><subject>Eczema</subject><subject>False information</subject><subject>Fear & phobias</subject><subject>Parents</subject><subject>Parents & parenting</subject><subject>Pediatrics</subject><subject>Phobias</subject><subject>Psychological aspects</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>Steroids</subject><subject>Surveys</subject><subject>Topical medication</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkU1rGzEQhpfSQkOSU_-AIJdAcaIPb0abm9k2TSDBJknPy6xWsuXsrlyNTMklv70yCeSDag6aGZ73ZZgpim-CnyhV8dO1GYSU4kwL9anYkxxgwpVWn9_kX4tDojXPT-upFLBXPNUhJm_CZhVajwyHMC7ZAqMdE7HgWL3yfZcr9tenFZulsPGG_bBxwOSTp3M2I7JEPqtucB0iw7FjN37M2a2nB3aBJoVIzOXGpV-u2P18cVXPF-zOhGjpoPjisCd7-PLvF78vft7Xl5Pr-a-renY9MarSaeIAnJCdECaPrUTrVGfOuK6qslQdyBYdVrI1ILBUTluBGqAE5BKgcy1KtV8cP_tuYviztZSawZOxfY-jDVtqpM5mVSmgyujRB3QdtnHM0-0oLYDrcvpKLbG3jR9dSBHNzrSZAchSqSmITJ38h8rR2SEvfbTO5_47wfdngYmBKFrXbKIfMD42gje7Kzdvrqz-AURMl9U</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Herzum, Astrid</creator><creator>Occella, Corrado</creator><creator>Gariazzo, Lodovica</creator><creator>Pastorino, Carlotta</creator><creator>Viglizzo, Gianmaria</creator><general>MDPI AG</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6373-8801</orcidid></search><sort><creationdate>20231101</creationdate><title>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</title><author>Herzum, Astrid ; Occella, Corrado ; Gariazzo, Lodovica ; Pastorino, Carlotta ; Viglizzo, Gianmaria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-f77f12d11c84231bf3dc60899553d72bafa92bc71a53f8e1a87757a0277dfba23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Allergy in children</topic><topic>Atopic dermatitis</topic><topic>Atrophy</topic><topic>Clinical medicine</topic><topic>Corticosteroids</topic><topic>Dermatitis</topic><topic>Dermatology</topic><topic>Drug therapy</topic><topic>Eczema</topic><topic>False information</topic><topic>Fear & phobias</topic><topic>Parents</topic><topic>Parents & parenting</topic><topic>Pediatrics</topic><topic>Phobias</topic><topic>Psychological aspects</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>Steroids</topic><topic>Surveys</topic><topic>Topical medication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Herzum, Astrid</creatorcontrib><creatorcontrib>Occella, Corrado</creatorcontrib><creatorcontrib>Gariazzo, Lodovica</creatorcontrib><creatorcontrib>Pastorino, Carlotta</creatorcontrib><creatorcontrib>Viglizzo, Gianmaria</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herzum, Astrid</au><au>Occella, Corrado</au><au>Gariazzo, Lodovica</au><au>Pastorino, Carlotta</au><au>Viglizzo, Gianmaria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores</atitle><jtitle>Journal of clinical medicine</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>12</volume><issue>21</issue><spage>6813</spage><pages>6813-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract><![CDATA[Corticophobia, fear of applying topical corticosteroids (TCSs), is a rising issue in industrialized countries, despite the actual safety of TCSs for atopic dermatitis (AD). Patients attending the Pediatric Dermatology Unit for skin examination were screened for AD. AD patients were included, and data were collected. Parental corticophobia was evaluated through the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The χ2 test and logistic regression were used to analyze statistical associations between parental corticophobia (mild/moderate vs. severe) and patients’ and parents’ characteristics. Overall, 100 patients were included (53 females; 47 males; mean age 5.9 years): 44 had mild/moderate AD (EASI ≤ 21), and 56 had severe AD (EASI > 21) (mean EASI 19.7). Of the patients, 33 never consulted healthcare providers for AD, and 67 did. Parental education was low/intermediate in 60 cases and high (gymnasium/university degree) in 40. Mean parental DLQI was 10.7. Mean parental TOPICOP was 39.1%: 51 had mild/moderate corticophobia (TOPICOP ≤ 50%), and 49 had severe corticophobia (TOPICOP > 50%). At the χ2 test, corticophobia was associated with mild/moderate AD (OR 20.9487; 95% CI 7.2489–60.5402; p < 0.001), older age of patients (OR 4.1176; 95% CI 1.7880 to 9.4828; p < 0.001), early disease onset (OR 9.8925; 95% CI 2.7064–36.1596; p < 0.001), and previous healthcare professional consultations (OR 4.9279; 95% CI 1.9335–12.5597; p < 0.001). Also, severe parental corticophobia was very significantly associated with severe parental involvement of life quality (OR 33.3333; 95% CI 10.9046–101.8937; p < 0.001) and with high education of parents (gymnasium or university degree) (29/49) (OR 5.2727; 95% CI 2.1927–12.6790; p < 0.001). At logistic regression, high parental DLQI (p < 0.0001), high parental education (p < 0.0338), older age of patients (p = 0.0015), and early disease onset (p < 0.0513) accounted for major risk factors influencing severe parental corticophobia. Assessing risk factors for corticophobia is essential for addressing groups of parents at higher risk for corticophobia using educational programs, to overcome unfounded fears and augment treatment adherence.]]></abstract><cop>Basel</cop><pub>MDPI AG</pub><doi>10.3390/jcm12216813</doi><orcidid>https://orcid.org/0000-0001-6373-8801</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2023-11, Vol.12 (21), p.6813 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_proquest_miscellaneous_2889995179 |
source | MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Allergy in children Atopic dermatitis Atrophy Clinical medicine Corticosteroids Dermatitis Dermatology Drug therapy Eczema False information Fear & phobias Parents Parents & parenting Pediatrics Phobias Psychological aspects Questionnaires Risk factors Steroids Surveys Topical medication |
title | Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A29%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corticophobia%20among%20Parents%20of%20Children%20with%20Atopic%20Dermatitis:%20Assessing%20Major%20and%20Minor%20Risk%20Factors%20for%20High%20TOPICOP%20Scores&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Herzum,%20Astrid&rft.date=2023-11-01&rft.volume=12&rft.issue=21&rft.spage=6813&rft.pages=6813-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm12216813&rft_dat=%3Cgale_proqu%3EA772533471%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2888170854&rft_id=info:pmid/&rft_galeid=A772533471&rfr_iscdi=true |